Patient Square Capital’s Eargo, Inc. Common Stock EAR Stock Holding History

Patient Square Capital’s Portfolio EAR Stock Details EAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,821,299	Closed	-$41M	–	3
2023 Q4	$41M	Hold	15,821,299	–	–	22.4%	2
2023 Q3	$34.3M	Hold	15,821,299	–	–	18.87%	2
2023 Q2	$78M	Hold	15,821,299	–	–	37.97%	2
2023 Q1	$74M	Hold	15,821,299	–	–	59.51%	1
2022 Q4	$182M	Buy	+15,821,299	New	+$203M	76.94%	1

Patient Square Capital's EAR Position: Q1 2024 in Review

Patient Square Capital sold out of Eargo, Inc. Common Stock (EAR) in Q1 2024, closing a stake of 15,821,299 shares — an estimated $41M sold.

Patient Square Capital first reported a position in EAR in Q4 2022 and held it in 5 quarters. The position peaked at $182M in Q4 2022. 0 funds tracked by Wall St. Rank hold EAR as of Q1 2024.

Patient Square Capital reported no remaining Eargo, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Patient Square Capital sold 15,821,299 Eargo, Inc. Common Stock shares in Q1 2024, an estimated $41M.
Patient Square Capital first reported a position in Eargo, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
Patient Square Capital's Eargo, Inc. Common Stock position peaked at $182M in Q4 2022.
0 funds tracked by Wall St. Rank held Eargo, Inc. Common Stock as of Q1 2024.

Based on Patient Square Capital's 13F filing for Q1 2024, filed 14 May 2024.